Bain Capital Life Sciences Investors, LLC Q2 2018 Filing

Filed August 14, 2018

Portfolio Value

$319.1B

Holdings

5

Report Date

Q2 2018

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
—DICERNA PHARMACEUTICALS INC
8,930,237$109.4B34.28%
2
SLDBSOLID BIOSCIENCES INC
1,989,444$70.9B22.21%
3
IFRXINFLARX NV
1,766,038$57.0B17.85%
4
—APTINYX INC
2,225,092$53.8B16.85%
5
—MARINUS PHARMACEUTICALS INC
3,977,453$28.1B8.81%